Print

Omnicare, Inc. (OCR) Comments on Federal Trade Commission Position  
1/30/2012 6:28:40 AM

COVINGTON, Ky.--(BUSINESS WIRE)--Omnicare, Inc. (NYSE:OCR) today issued the following statement responding to the Federal Trade Commission’s (FTC) split (3 to 1) decision to issue an administrative complaint to block Omnicare’s offer to purchase all outstanding shares of PharMerica Corporation (NYSE: PMC) common stock for $15.00 per share in cash.
//-->